Lawrence A. Reiter

1.3k citations

32 papers · 697 indexed · h-index 15

Co-authors: John J. Martin Edward C. Taylor Brian P. Jones Peter G. Mitchell Michael J. Munchhof Kevin M. Koch Henry J. Showell William H. Brissette
Topics: Peptidase Inhibition and Analysis (6 papers)Protease and Inhibitor Mechanisms (6 papers)Chemical Synthesis and Analysis (5 papers)
Cited by: Organic Chemistry Molecular Biology Hematology
Journals: Journal of the American Chemical Society PLoS ONE The FASEB Journal
Partner nations: United States Australia

In The Last Decade

Lawrence A. Reiter

32 papers receiving 661 citations

Peers

Countries citing papers authored by Lawrence A. Reiter

Since Specialization

Citations

This map shows the geographic impact of Lawrence A. Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence A. Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence A. Reiter more than expected).

Fields of papers citing papers by Lawrence A. Reiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence A. Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence A. Reiter. The network helps show where Lawrence A. Reiter may publish in the future.

Co-authorship network of co-authors of Lawrence A. Reiter

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence A. Reiter. A scholar is included among the top collaborators of Lawrence A. Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence A. Reiter. Lawrence A. Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666 2015 ·ACS Medicinal Chemistry Letters ·Kenneth W. Duncan,Nathalie Rioux,P. Ann Boriack‐Sjodin,Michael J. Munchhof,Lawrence A. Reiter,Christina R. Majer,Lei Jin,L. Danielle Johnston,Elayne Chan-Penebre,(unknown),Margaret Porter Scott,Roy M. Pollock,Nigel J. Waters,J. Joshua Smith,Mikel P. Moyer,Robert A. Copeland,Richard Chesworth	103
2	An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer 2012 ·PLoS ONE ·Manisha H. Shah,D. Huang,Tony Blick,(unknown),Lawrence A. Reiter,Joel R. Hardink,Conor C. Lynch,Mark Waltham,Erik W. Thompson	3
3	Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation 2011 ·The FASEB Journal ·Erin Matthews,Damien Thévenin,Julia M. Rogers,(unknown),Paul D. Lira,Lawrence A. Reiter,William H. Brissette,Donald M. Engelman	55
4	Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),William H. Brissette,Matthew F. Brown,Jeffrey Casavant,Jonathan L. Doty,James P. Driscoll,Thomas M. Harris,Christopher S. Jones,Sandra P. McCurdy,Eric B. McElroy,Mark J. Mitton‐Fry,Michael J. Munchhof,(unknown),Lawrence A. Reiter,Sharon L. Ripp,Andrei Shavnya,(unknown),(unknown)	7
5	Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter,Christopher S. Jones,William H. Brissette,Sandra P. McCurdy,Yuriy A. Abramov,Jon Bordner,Frank M. DiCapua,Michael J. Munchhof,(unknown),I. Samardjiev,Jane M. Withka	10
6	Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1 2004 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter	2
7	Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3 2003 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter,Peter G. Mitchell,(unknown),Lori Lopresti‐Morrow,Sue A. Yocum,James D. Eskra	27
8	Difluoroketones as inhibitors of matrix metalloprotease-13 2000 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter,(unknown),(unknown),Peter G. Mitchell	22
9	Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket 1999 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter,James P. Rizzi,Jayvardhan Pandit,(unknown),(unknown),Vinod D. Parikh,James F. Blake,Dennis E. Danley,Ellen R. Laird,Arturo Lopez‐Anaya,Lori Lopresti‐Morrow,Mahmoud N. Mansour,(unknown),Peter G. Mitchell,(unknown),Thomas Pauly,(unknown),Gayle K. Schulte,Sue A. Yocum	31
10	trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter,Kevin M. Koch,Anthony D. Piscopio,Henry J. Showell,(unknown),Michael S. Biggers,Robert Chambers,Maryrose J. Conklyn,Kelvin Cooper,(unknown),Joseph DiBrino,Beryl W. Dominy,Cathy A. Farrell,Gary P. Hingorani,(unknown),(unknown),(unknown)	11
11	The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Henry J. Showell,Maryrose J. Conklyn,(unknown),Gary P. Hingorani,(unknown),Mary Alice Smith,Ethan J. Stam,E.D. Salter,(unknown),Susan S. Meltzer,Lawrence A. Reiter,Kevin M. Koch,Anthony D. Piscopio,(unknown),Arturo Lopez‐Anaya,E. R. Pettipher,Anthony J. Milici,R. Griffiths	37
12	Amide-Assisted Hydrolysis of β-Carboxamido-Substituted Phosphinic Acid Esters 1997 ·The Journal of Organic Chemistry ·Lawrence A. Reiter,Brian P. Jones	25
13	Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group 1996 ·Journal of Medicinal Chemistry ·Ralph P. Robinson,Lawrence A. Reiter,Wayne E. Barth,(unknown),Kelvin Cooper,(unknown),(unknown),Kathleen M. Donahue,Fred C. Falkner,Eugene F. Fiese,(unknown),(unknown),Theodore E. Liston,(unknown),John J. Martin,David Mitchell,(unknown),Sheri L. Shamblin,(unknown)	63
14	(+)-1-(3S,4R)-[3-(4-Phenylbenzyl)-4- hydroxychroman-7-yl]cyclopentane Carboxylic Acid, a Highly Potent, Selective Leukotriene B4 Antagonist with Oral Activity in the Murine Collagen-Induced Arthritis Model 1994 ·Journal of Medicinal Chemistry ·Kevin M. Koch,Lawrence S. Melvin,Lawrence A. Reiter,Michael S. Biggers,Henry J. Showell,R. Griffiths,E. R. Pettipher,John B. Cheng,Anthony J. Milici	48
15	Inhibition of Interleukin‐1—Stimulated Collagen Degradation in Cartilage Explants 1994 ·Annals of the New York Academy of Sciences ·Peter G. Mitchell,Lori Lopresti‐Morrow,Sue A. Yocum,Francis J. Sweeney,Lawrence A. Reiter	3
16	Peptidic p‐nitroanilide substrates of interleukin‐1β‐converting enzyme 1994 ·International journal of peptide & protein research ·Lawrence A. Reiter	14
17	Interleukin‐1β converting enzyme 1993 ·International journal of peptide & protein research ·Lawrence A. Reiter,John J. Martin	39
18	CP-66,948: An antisecretory histamine H2-receptor antagonist with mucosal protective properties 1991 ·Digestive Diseases and Sciences ·(unknown),William F. Holt,(unknown),Peter J. Oates,William R. Murphy,James J. Maciejko,Lawrence A. Reiter	8
19	Antiulcer agents. 4-Substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K+-ATPase 1990 ·Journal of Medicinal Chemistry ·John L. LaMattina,(unknown),Lawrence A. Reiter,William F. Holt,(unknown)	20
20	A general synthesis of 4(5)-acylimidazoles from 4-acylaminoisoxazoles. 1985 ·Tetrahedron Letters ·Lawrence A. Reiter	1

About Lawrence A. Reiter

Lawrence A. Reiter is a scholar working on Pharmaceutical Science, Organic Chemistry and Cancer Research, having authored 32 papers that have together received 697 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Organic Chemistry (268 citations), Molecular Biology (358 citations) and Hematology (52 citations). Lawrence A. Reiter has collaborated with scholars based in United States and Australia. Frequent co-authors include John J. Martin, Edward C. Taylor, Brian P. Jones, Peter G. Mitchell, Michael J. Munchhof, Kevin M. Koch, Henry J. Showell, William H. Brissette, Donald M. Engelman and Edward C. Taylor. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact